Validating AIM-Based Instrumentation and Associated Measurement Techniques - Good Cascade Impactor Practices, AIM and EDA for Orally Inhaled Products - page 306

Fig. 10.27 Comparisons of measures of CPF >5.0μm , FPF <5.0μm , and EPF <1.0μm for 8-different pMDI
products comparing FPD-AVCI and nonviable 8-stage ACI. %LC percent label claim ( From
[ 33 ]— courtesy of W. Doub )